Animal | Model | Preconditioning time/approach | TLR/ischemia | Result and mechanism | Author | Reference |
---|---|---|---|---|---|---|
Mice | MCAO, 60-min ischemia, 24-h reperfusion | 72 h/12-min ischemia | Ischemic preconditioning | Decrease brain infarction volume, and IRF gene participate in brain protection | Stevens SL | [79] |
Mice | MCAO, 60-min ischemia, 6-h reperfusion | 24 h/IP | TLR2, Pam3CSK4 | Decrease brain infarction and edema, improve neurological function, and maintain BBB function | Hua F | [60] |
Mice | MCAO, 45-min ischemia, 24-h reperfusion | 72 h/subcutaneous injection | TLR3, poly-ICLC | Decrease brain infarction volume and improve neurological function | Packard AEB | [63] |
Mice | MCAO, 120-min ischemia, 22-h reperfusion | 24 h/systemic injection | TLR3 poly-IC | Decrease brain infarction volume and neurological defect and lower the levels of TNF-α and IL-6 in cortex and striatum | Pan LN | [66] |
Mice | MCAO, 60-min ischemia, 24-h reperfusion | 1 h/IP | TLR3 poly-IC | Decrease brain infarction and prevention of Fas/FADD interaction | Zhang X | [67] |
Spontaneously hypertension rats | MCAO, 120-min ischemia, 22-h reperfusion | 2, 3, 4 days/IV | TLR4 LPS | Decrease brain infarction volume, mediated by TNF-α | Tasaki K | [72] |
Mice | MCAO, 120-min ischemia, 47-h reperfusion | 48 h/IP | TLR4 LPS | Decrease brain infarction volume, inhibit the infiltration of neutrophil and activation of the microglia | Rosenzweig HL | [73] |
Mice | MCAO, 40-, 45-, 60-min ischemia, 24-h reperfusion | 72 h/IP | TLR4 LPS | Decrease brain infarction volume that was mediated by IRF3 | Marsh B | [61] |
Mice | MCAO, 40-to 60-min ischemia, 24-h reperfusion | 72 h/subcutaneous injection | TLR4 LPS | Decrease brain infarction volume, and TRIF-IRF3 play vital role | Vartanian KB | [58] |
Mice | MCAO, 60-min ischemia, 24-h reperfusion | 72 h/IP | TLR4 | Decrease brain infarction volume, and inhibit TNF-α signaling pathway after cerebral ischemia | Rosenzweig HL | [76] |
Mice | MCAO, 45-to 60-min ischemia, 23-h reperfusion | 72 h/subcutaneous injection | TLR7 GDQ | Decrease brain infarction volume and neurological functional score that was protected through I type interferon | Leung PY | [62] |
Mice | MCAO, 60-min ischemia, 72-h reperfusion | 30 min/IV | TLR8 R848 | Increase neurological function defect and mortality, activate pro-apoptotic JNK pathway and inflammation | Tang SC | [56] |
Mice | MCAO, 60-min ischemia, 24-h reperfusion | 72 h/IP | TLR9 CpG-ODN | Decrease brain infarction volume and TNF-α play a vital role | Stevens SL | [64] |
Mice | MCAO, 60-min ischemia, 24-h reperfusion | 72 h/IP or subcutaneous injection | TLR9 CpG-ODN | Decrease brain infarction volume and IRF gene participate in cerebral protection after ischemia | Stevens SL | [79] |
Mice | MCAO, 60-min ischemia, 24-h reperfusion | 1 h/IP | TLR9 CpG-ODN | Decrease brain infarction and activation of PI3K/Akt signaling | Lu C | [78] |